Latvia vs Slovenia: HICP - Tea, mate and other plant-derived products for infusion (ND)
Latvia
1.88
in 2026
Slovenia
2.18
in 2026
Latvia rank
4th
Slovenia rank
2nd
HICP - Tea, mate and other plant-derived products for infusion (ND) over time
- Latvia
- Slovenia
How they compare
Slovenia currently reports 2.18 against 1.88 in Latvia, a difference of 0.3.
That makes Slovenia's figure about 1.2 times Latvia's.
The two have swapped places 1 time across 27 shared years of data; in 2000 it was Latvia ahead.
Latvia ranks 4th and Slovenia ranks 2nd of 27 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.28 | 1.32 | 0.958 | Latvia |
| 2010s | 1.78 | 1.04 | 0.747 | Latvia |
| 2020s | 2.31 | 1.59 | 0.7157 | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hicp - tea, mate and other plant-derived products for infusion (nd), Latvia or Slovenia?
- Slovenia, at 2.18 against 1.88 in Latvia as of 2026.
- What is the difference in hicp - tea, mate and other plant-derived products for infusion (nd) between Latvia and Slovenia?
- 0.3, with Slovenia ahead.
- How many years of comparable data are there for Latvia and Slovenia?
- 27 years are reported by both, from 2000 to 2026.
- How do Latvia and Slovenia rank globally for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Latvia ranks 4th and Slovenia ranks 2nd of 27 countries.
- Where does this data come from?
- European Central Bank, published as HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid refreshes it automatically from the source and publishes the full history for both places.